Skip to content
Project Curia

Watching the government

← Back

Director, Office of National Drug Control Policy

Sara Bailey Securities trades and financial disclosures

Sara Bailey's OGE filings report 5 securities transactions dated February 1, 2026 to March 1, 2026, as read here on October 12, 2026.

Trading profile

Buys vs. sells

80% bought · 20% sold

Past the deadline

1

after 45 days plus any extension the filing states

Est. volume

$5K

lower-bound estimate

On Bailey’s reports

By asset type

5 trades

  1. Individual stock
    3
  2. Funds and ETFs
    1
  3. Other
    1

Trading over time

5
2026

Net worth

A net worth for Sara Bailey cannot be computed from this filing: values are given as ranges, some items carry no value, and a home kept for personal use is not reported.

Disclosed holdings

Disclosed assets

$817K to $1.9M

as ranges on 17 line items, plus 12 without a dollar value

Disclosed liabilities

$535K to $1.1M

as ranges on 4 line items

The full record

The disclosed transactions.

5 disclosed transactions, as filed on the official’s OGE 278-T. Amounts are ranges, never exact. Every row links to the official filing.

Sort by
Bought
GE Verona
$1,001 - $15,000Unspecified2026-03-01↗
Bought
Fidelity Advisor Biotechnology Fund Class C Shares (FBTCX)
FBTCX
$1,001 - $15,000Unspecified2026-03-01↗
Sold
TMC the metals company Inc. Common Stock (TMC)
TMC
$1,001 - $15,000Unspecified2026-03-01↗
Bought
Byrna Technologies Inc. Common Stock (BYRN)
BYRN
$1,001 - $15,000Unspecified2026-03-01↗
Bought
TMC the metals company Inc. Common Stock (TMC)
TMC
$1,001 - $15,000Unspecified2026-02-01↗